12
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T21781 | A-286982 | Integrin | |
A 286982 is an inhibitor that blocks the integrin-ligand interaction between leukocyte function-associated antigen-1 (LFA-1) and intercellular adhesion molecule-1. | |||
T3977 | Lifitegrast | SHP-606,SAR 1118 | Integrin |
Lifitegrast (SAR 1118) is a lymphocyte, function-associated antigen-1 antagonist. | |||
T14676 | BMS-688521 | Integrin | |
BMS-688521 BMS-688521 is an orally active and potent inhibitor of LFA-1/ICAM interaction, a small molecule antagonist of leukocyte function-associated antigen-1 (LFA-1), with potential anti-inflammatory activity. | |||
T12783 | RWJ 50271 | Integrin | |
RWJ 50271 is a selective lymphocyte function-associated antigen-1/intercellular adhesion molecule-1(LFA-1/ICAM-1) interaction inhibitor( IC50 of 5.0 μM in HL60 cells). | |||
T23796 | BIRT-377 | BIRT377,BIRT 377 | IL Receptor , Integrin |
BIRT-377 is a negative allosteric and orally bioavailable inhibitor of ICAM-1 and LFA-1(Ki = 25.8 nM). BIRT-377 inhibits the production of IL-2 and can be used in studies about inflammatory and immune disorders. | |||
T76924 | Efalizumab | Hu1124,HU 1124 | Integrin |
Efalizumab, a novel potent regulator of T cells, is a humanized LFA-1 α subunit (CD11a) monoclonal antibody. Efalizumab has inhibitory effects on T cell activation, skin T cell transport, and T cell adhesion to keratinoc... | |||
T24155 | ICAM-1988 | ICAM 1988 | |
ICAM-1988 is a LFA-1 antagonist. | |||
T14558 | BI-1950 | Integrin | |
BI-1950 is a highly potent lymphocyte function associated antigen-1 (LFA-1) inhibitor and the LFA-1 is an essential component in normal immune system function and a target for drug discovery[1]. | |||
T30533 | BMS-587101 | UNII-5V7E4UQL93 | |
BMS-587101 is a small molecule antagonist of LFA-1, which can reduce inflammation and joint destruction in the mouse model of arthritis. | |||
T3977L | Lifitegrast sodium | SAR-1118-023,SAR1118-023,SAR 1118-023,Xiidra | |
Lifitegrast sodium (SAR-1118) is an LFA-1 antagonist for the therapy of vascular complications of the eye. It inhibits T cell-mediated inflammation by blocking the binding of two cell surface proteins (lymphocyte functio... | |||
T40274 | XVA143 | XVA143 | |
XVA143, an α/β I-like allosteric antagonist, effectively blocks LFA-1 dependent firm adhesion but simultaneously increases adhesion under shear flow and rolling conditions, both in vitro and in vivo. | |||
T77106 | Odulimomab | ||
Odulimomab (anti-LFA1), an anti-LFA-1 monoclonal antibody, inhibits T lymphocyte proliferation and provides protection against ischemia and reperfusion injury. It is utilized in researching transplant rejection and immun... |